Valuation: Electromed, Inc.

Market Cap 236M 210M 196M 179M 337M 22.74B 341M 2.37B 919M 11.58B 887M 868M 37.2B P/E 2027 *
19.6x
P/E 2028 * 16.9x
Enterprise Value 236M 210M 196M 179M 337M 22.74B 341M 2.37B 919M 11.58B 887M 868M 37.2B EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.57x
Free-Float
82.82%
Yield 2027 *
-
Yield 2028 * -
1 day+0.96%
1 week+2.30%
Current month+0.96%
1 month+5.17%
3 months-35.33%
6 months+20.51%
Current year-2.13%
1 week 27.27
Extreme 27.27
28.95
1 month 25.81
Extreme 25.81
28.95
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Chief Financial Officer

15,602 0.1865%
1/9/26 Tax

Chief Executive Officer

-2,671 0.0319%
30/6/26 Tax

Chief Financial Officer

-674 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+2.30%+16.09%+174.30% 236M
-3.34%-3.81%+22.95%+28.91% 241B
-4.42%-5.37%-0.53%-14.65% 149B
-1.33%+0.43%-8.40%+37.27% 142B
-0.96%-3.25%-54.90%-18.12% 62.65B
-1.31%-0.63%+11.64%+22.96% 49.1B
-3.27%-3.56%+20.28%+49.06% 46.99B
+0.62%+0.11%-19.36%-21.30% 47.13B
-1.23%+2.58%-3.86%+38.57% 45.65B
-3.15%-1.11%+33.06%+55.18% 41.81B
Average -0.37%+0.50%+1.70%+35.22% 82.54B
Weighted average by Cap. -0.60%+0.45%+3.21%+18.75%

Financials

2027 *2028 *
Net sales 83.15M 73.85M 69.07M 62.94M 118M 8.01B 120M 836M 323M 4.08B 312M 305M 13.1B 92.05M 81.76M 76.46M 69.67M 131M 8.86B 133M 925M 358M 4.51B 346M 338M 14.5B
Net income 12.6M 11.19M 10.47M 9.54M 17.96M 1.21B 18.2M 127M 49.01M 618M 47.31M 46.28M 1.98B 14.75M 13.1M 12.25M 11.16M 21.02M 1.42B 21.31M 148M 57.38M 723M 55.38M 54.18M 2.32B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
01/10/26 USD 28.50 +0.96% 86,731
30/09/26 USD 28.23 -0.35% 145,071
29/09/26 USD 28.33 +0.57% 95,702
28/09/26 USD 28.17 +1.04% 87,810
25/09/26 USD 27.88 +0.07% 92,768
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.50USD
Average target price
48.50USD
Spread / Average Target
+70.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock